Insider Activity of Foundation Fighting Blindness Retinal Degeneration Fund
According to the SEC Form 4 filings, Foundation Fighting Blindness Retinal Degeneration Fund, being in a position of
- See Remarks at Opus Genetics, Inc.,оver the last 12 months, has bought 0 shares, and sold 6256000 shares for $18.75M,over all time since 2025-12-09, has bought 0 shares, and sold 6256000 shares for $18.75M.
Biography of Foundation Fighting Blindness Retinal Degeneration Fund
No biography is available at this moment.